| Trade name | SS-31 10mg (Not available for sale in certain jurisdictions) | CAS Number | 736992-21-5 |
| Chemical name | SS-31 10mg (Not available for sale in certain | Molecular formula | C32H49N9O5 |
| Catalogue № | Molecular weight | 639.8 g/mol | |
| Pack size | 10.0 mg | Physical form | 10mg |
1.2 Relevant identified uses of the substance and uses advised against
For research use only (in vitro). Not for human or veterinary use, including diagnostic, therapeutic, prophylactic or in vivo administration of any kind. Not for use in or as a food, drug, medical device, cosmetic, household product, or any other commercial application.
1.3 Details of the supplier of the Safety Data Sheet
1.4 Emergency telephone number
2.1 Classification of the substance or mixture
Not classified as hazardous under UK CLP (Regulation (EC) No 1272/2008 as retained).
2.2 Label elements
2.3 Other hazards
No other hazards known under conditions of normal handling. As a research-use-only substance with limited published toxicological data, handle with the precautions appropriate to a substance of unknown toxicity.
Substance type: Substance (single component)
| Component | CAS № | EC № | Concentration |
|---|---|---|---|
| SS-31 10mg (Not available for sale in certain | 736992-21-5 | Not assigned | >98 (purity by HPLC) |
4.1 Description of first-aid measures
4.2 Most important symptoms and effects, acute and delayed
No specific symptoms known. As a research compound with limited toxicological characterisation, observe casualty for delayed effects.
4.3 Indication of any immediate medical attention and special treatment needed
Treat symptomatically. No specific antidote known.
7.1 Precautions for safe handling
Handle only in a properly ventilated laboratory by trained personnel. Avoid formation of dust and aerosols. Avoid contact with skin, eyes and clothing. Wash thoroughly after handling. Do not eat, drink or smoke when using this product.
7.2 Conditions for safe storage, including any incompatibilities
Store the unopened, lyophilised product at -20 °C, protected from light and moisture, in the original sealed container. Prepared solutions should be stored according to validated laboratory procedures.
7.3 Specific end uses
For research use only (in vitro). See section 1.2.
8.1 Control parameters
No occupational exposure limits (WELs, OELs, TLVs) have been established for this substance.
8.2 Exposure controls
11.1 Information on toxicological effects
No specific toxicological data is available for this substance. Limited toxicological data is available and the precautionary principle should be applied.
13.1 Waste treatment methods
| Mode | UN № | Proper shipping name | Hazard class | Packing group |
|---|---|---|---|---|
| ADR (road) | Not regulated | Not regulated | Not regulated | Not regulated |
| RID (rail) | Not regulated | Not regulated | Not regulated | Not regulated |
| IMDG (sea) | Not regulated | Not regulated | Not regulated | Not regulated |
| IATA / ICAO (air) | Not regulated | Not regulated | Not regulated | Not regulated |
UK REACH
UK REACH — Regulation (EC) No 1907/2006 as it applies in Great Britain by virtue of the REACH etc. (Amendment etc.) (EU Exit) Regulations 2019 (SI 2019/758), as amended. This substance is not listed on the UK REACH Candidate List of Substances of Very High Concern (SVHC) and is not subject to authorisation under UK REACH Annex XIV.
UK CLP
UK CLP — Regulation (EC) No 1272/2008 as it applies in Great Britain by virtue of the CLP etc. (Amendment etc.) (EU Exit) Regulations 2019 (SI 2019/720), as amended. The substance does not have a harmonised classification under UK CLP Annex VI and is not classified by the supplier as hazardous.
MHRA
This product is not authorised as a medicinal product by the UK Medicines and Healthcare products Regulatory Agency (MHRA) under the Human Medicines Regulations 2012. Any supply, marketing, or use must comply with applicable UK legislation, including the Human Medicines Regulations 2012. This product is supplied solely as a chemical reagent for in vitro research.
Other UK legislation
Chemical safety assessment
A Chemical Safety Assessment under UK REACH has not been carried out by the supplier.
Review history
| Date | Reviewed by | Outcome |
|---|---|---|
| 2026-05-27 | UK Peptides Compliance Team | Initial issue |
| 2026-07-01 | UK Peptides Compliance Team | Quarterly review — no changes required |
Abbreviations and acronyms
References
The information in this Safety Data Sheet is provided in good faith and is believed to be correct as of the date of issue. UK Peptides makes no warranty, express or implied, regarding the accuracy of this data or the results to be obtained from its use. This product is supplied for research use only (in vitro). The user assumes all responsibility for the safe use, handling, storage and disposal of the product, and for compliance with all applicable laws and regulations. This SDS does not constitute a quality specification — quality data is supplied separately on the Certificate of Analysis.
This document is provided for occupational safety and transport reference purposes only and does not constitute product approval, authorisation, or suitability for any specific application.